Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

MS Aapro, Heidy Wijk, MEL Burg, WW ten Bokkel Huinink, I Vergote, JP Guastalla, R Rosso, A Kobierska, LVAM Beex, M Namer, Ted Splinter, JB Vermorken

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1141-1143
Number of pages3
JournalEuropean Journal of Cancer
Publication statusPublished - 2003

Research programs

  • EMC MM-03-86-08

Cite this